EBCOF yields 1.21% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, EBCOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EBCOF + JNJ for your $10,000?
Ebara Corporation manufactures and sells industrial machinery. It operates through Fluid Machinery & Systems Business, Environmental Plants Business, and Precision Machinery Business segments. The company offers large, high pressure, API, cryogenic, and standard pumps, as well as blowers and fans to water and energy facilities; centrifugal and axial compressors, steam turbines, and gas expanders to oil refining and petrochemical plants; and centrifugal chillers, absorption chillers/heaters, square/round type cooling towers, and screw modular chillers. It also engages in the design, construction, maintenance, and operation management of environmental plants, such as municipal solid waste incineration power plants, waste treatment facilities and equipment, waste recycling facilities, and biomass power generation facilities. In addition, the company offers precision machineries, such chemical mechanical polishing systems, plating systems, bevel polishing equipment, and gas abatement systems, as well as dry vacuum and turbo molecular pumps; and semiconductor manufacturing equipment. Ebara Corporation was founded in 1912 and is headquartered in Tokyo, Japan.
Full EBCOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.